Correction: Corrigendum: IAPP boosts islet macrophage IL-1 in type 2 diabetes

被引：0
|
作者：
Thomas Mandrup-Poulsen
机构：
来源：
Nature Immunology | 2011年 / 12卷 / 3期
关键词：
D O I：
10.1038/ni0311-271c
中图分类号：
学科分类号：
摘要：
Nat. Immunol. 11, 881–883 (2010); published online 20 September 2010; corrected after print 21 October 2010. In the version of this article initially published, some of the text on p 882 was inaccurate. The correct text should read as follows: “thereby counteracting the beneficial effects of blocking IAPP on islet inflammation” (middle column) and “This mechanism has been suggested to mediate ROS-dependent inflammasome activation induced by high concentrations of glucose in mouse pancreatic beta cells12, although this finding is now being debated” (right column, first full paragraph, second sentence).
引用
收藏
页码：271 / 271
相关论文
共 50 条
  • [21] Correction: Corrigendum: Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes
    Elmar Jaeckel
    Myra A Lipes
    Harald von Boehmer
    Nature Immunology, 2004, 5 : 1190 - 1190
  • [22] Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes
    Morris, David L.
    MOLECULAR ENDOCRINOLOGY, 2015, 29 (07) : 946 - 962
  • [23] Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes
    Luotola, K.
    Pietila, A.
    Zeller, T.
    Moilanen, L.
    Kahonen, M.
    Nieminen, M. S.
    Kesaniemi, Y. A.
    Blankenberg, S.
    Jula, A.
    Perola, M.
    Salomaa, V.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (03) : 322 - 332
  • [24] Effects of IL-1 on the revascularization of islet grafts
    Castaner, O.
    Tellez, N.
    Estilles, E.
    Joanny, G.
    Escoriza, J.
    Montanya, E.
    DIABETOLOGIA, 2008, 51 : S242 - S243
  • [25] The Impact of IL-1 in Islet Antiviral Responses
    Bartosiak, Jacob
    Corbett, John A.
    DIABETES, 2024, 73
  • [26] IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes
    Berchtold, Lukas A.
    Larsen, Claus M.
    Vaag, Allan
    Faulenbach, Mirjam
    Workman, Christopher T.
    Kruhoffer, Mogens
    Donath, Marc
    Mandrup-Poulsen, Thomas
    EUROPEAN CYTOKINE NETWORK, 2009, 20 (02) : 81 - 87
  • [27] The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion
    Borowska, Magdalena
    Dworacka, Marzena
    Wesolowska, Anna
    Winiarska, Hanna
    Krzyzagorska, Ewa
    Dworacki, Grzegorz
    PHARMACOLOGY, 2016, 97 (3-4) : 189 - 194
  • [28] Serum IL-1, IL-2, TNFα and INFγ levels of patients with type 1 diabetes mellitus and their siblings
    Özer, G
    Teker, Z
    Çetiner, S
    Yilmaz, M
    Topaloglu, AK
    Önenli-Mungan, N
    Yüksel, B
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (02): : 203 - 210
  • [29] Islet cell function in type 1 and type 2 diabetes
    Hao, W
    Palmer, JP
    JOURNAL OF CLINICAL LIGAND ASSAY, 1998, 21 (03): : 309 - 317
  • [30] Correction: Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
    Jenny Aurielle B Babon
    Megan E DeNicola
    David M Blodgett
    Inne Crèvecoeur
    Thomas S Buttrick
    René Maehr
    Rita Bottino
    Ali Naji
    John Kaddis
    Wassim Elyaman
    Eddie A James
    Rachana Haliyur
    Marcela Brissova
    Lut Overbergh
    Chantal Mathieu
    Thomas Delong
    Kathryn Haskins
    Alberto Pugliese
    Martha Campbell-Thompson
    Clayton Mathews
    Mark A Atkinson
    Alvin C Powers
    David M Harlan
    Sally C Kent
    Nature Medicine, 2017, 23 (8) : 1004 - 1004
12345